Compounds > 5-methoxy-6-methyl-2-aminoindan
Page last updated: 2024-09-03

5-methoxy-6-methyl-2-aminoindan and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine

5-methoxy-6-methyl-2-aminoindan has been researched along with n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine in 5 studies

Compound Research Comparison

Studies
(5-methoxy-6-methyl-2-aminoindan)		Trials
(5-methoxy-6-methyl-2-aminoindan)		Recent Studies (post-2010)
(5-methoxy-6-methyl-2-aminoindan)		Studies
(n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine)		Trials
(n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine)		Recent Studies (post-2010) (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine)
13003711

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cozzi, NV; Marona-Lewicka, D; Monte, AP; Nichols, DE1
Kurrasch, D; Marona-Lewicka, D; Nichols, DE; Parker, MA; Shulgin, AT1
Marona-Lewicka, D; Nichols, DE2
Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD1

Other Studies

5 other study(ies) available for 5-methoxy-6-methyl-2-aminoindan and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine

ArticleYear
Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine.
    Journal of medicinal chemistry, 1993, Nov-12, Volume: 36, Issue:23

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Benzofurans; Brain; Discrimination Learning; Dopamine; Indenes; Male; Molecular Structure; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrahydronaphthalenes

1993
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
    Journal of medicinal chemistry, 1998, Mar-12, Volume: 41, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Dioxoles; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Serotonin Agents; Synaptosomes

1998
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    European journal of pharmacology, 1994, Jun-02, Volume: 258, Issue:1-2

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism

1994
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins

1996
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Psychopharmacology, 1998, Volume: 138, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists

1998